MedTrace Logo

Effects of Lactobacillus Plantarum PS128 on the Parkinsonian Symptoms in Parkinson's Disease.

NCT04722211 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2021-01-25

No results posted yet for this study

Summary

This RCT study is designed to examine the extent to which L. plantarum PS128 can improve symptoms in PD patients. L. plantarum PS128 is a psychobiotic that regulates the level of dopamine in specific brain regions. Patients with PD will receive PS128 or placebo intervention for 12 weeks. Symptoms of PD will be clinically evaluated before and after the treatment, and the results will be compared.

Conditions

  • Parkinson Disease

Interventions

DIETARY_SUPPLEMENT

PS128

daily ingestion of 2 capsules of Lactobacillus plantarum PS128 (\>10 billion CFU/capsule)

DIETARY_SUPPLEMENT

placebo

daily ingestion of 2 capsules which only contained 425 ± 25 mg microcrystalline cellulose

Sponsors & Collaborators

  • Professor Lu Neurological Clinic

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-06
Primary Completion
2022-12-31
Completion
2023-06-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04722211 on ClinicalTrials.gov